Tidelands Health

Tidelands Health
843-652-1607 or 843-652-8089

National Cancer Institute Community Oncology Research Program logo

As an affiliate of the Medical University of South Carolina, Tidelands Health is an active Minority/Underserved NCORP site. Tidelands Health is currently active on the following clinical trials addressing various cancer types. Ask your health care provider for more information.

All Disease Sites

  • WF-30917CD: Stepped-Care Telehealth for Distress in Rural Cancer Survivors
    Trial Details
  • WF-1901: An Internet-based Program to Help Cancer Survivors Manage Pain (IMPACTS)
    Trial Details

Breast

  • A011202: Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy
    Trial Details
  • A011801: T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial
    Trial Details
  • BR003: Testing the addition of carboplatin to usual chemotherapy in high-risk triple-negative breast cancer
    Trial Details
  • EAZ171: Testing if docetaxel or paclitaxel induces less peripheral neuropathy in African American women
    Trial Details
  • WF-97116: Donepezil for Cognitive Impairment (REMEMBER)
    Trial Details

Gastrointestinal

  • A021703: Testing the addition of high-dose vitamin D3 to usual chemotherapy treatment and bevacizumab for untreated advanced colorectal cancer
    Trial Details
  • A221805: Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer
    Trial Details
  • EA2165: Testing the Addition of the Drug Nivolumab after Previous Therapy for High Risk Anal Cancer
    Trial Details
  • EA2186: Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread
    Trial Details

Head & Neck

  • HN005: Testing less intensive radiation therapy with chemotherapy or immunotherapy to treat selected low-risk patients with HPV-positive oropharyngeal cancer
    Trial Details

Thoracic/Lung

  • A171901: Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer
    Trial Details
  • EA5163/S1709 INSIGNA: Testing the timing of immunotherapy alone or with chemotherapy as first line treatment and maintenance in non-small cell lung cancer
    Trial Details